Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
Cancer Res Treat. 2015 Oct;47(4):897-903. English. Original Article. https://doi.org/10.4143/crt.2014.135
Bindiganavile S , Han I , Yun JY , Kim HS .
Department of Orthopaedic Surgery, Seoul National University Hospital, Seoul, Korea. hik19@snu.ac.kr
Abstract

PURPOSE: The prognostic factors of chondrosarcoma remain uncertain as only a few large studies with long-term follow-up have been reported. The aim of this study was to analyze oncological outcomes and prognostic factors. MATERIALS AND METHODS: A retrospective review of oncological outcomes and prognostic factors was performed on 125 consecutive chondrosarcoma patients who underwent surgery at our institution. RESULTS: Overall survival was 91.6%+/-2.5%, 84.1%+/-3.8%, and 84.1%+/-3.8% at 5, 10, and 15 years respectively. Among the histological types, dedifferentiated type showed the worst survival (p < 0.001). As for conventional type chondrosarcoma, histologic grade and anatomical location predicted outcome, with high-grade with axial location having the worst outcome (p < 0.001). In contrast, low-grade chondrosarcoma of appendicular skeleton could be treated safely by intralesional curettage. CONCLUSION: Histological type was significantly associated with the outcome of chondrosarcoma. For the conventional type, histologic grade and anatomical location predicted outcome, with high-grade with axial location having the worst outcome.

Copyright © 2019. Korean Association of Medical Journal Editors.